logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Minimal Residual Disease And Circulating Tumor Cells In Breast Cancer 1st Edition Michail Ignatiadis

  • SKU: BELL-4404486
Minimal Residual Disease And Circulating Tumor Cells In Breast Cancer 1st Edition Michail Ignatiadis
$ 31.00 $ 45.00 (-31%)

4.3

48 reviews

Minimal Residual Disease And Circulating Tumor Cells In Breast Cancer 1st Edition Michail Ignatiadis instant download after payment.

Publisher: Springer-Verlag Berlin Heidelberg
File Extension: PDF
File size: 3.32 MB
Pages: 254
Author: Michail Ignatiadis, Christos Sotiriou, Klaus Pantel (auth.), Michail Ignatiadis, Christos Sotiriou, Klaus Pantel (eds.)
ISBN: 9783642281594, 9783642281600, 3642281591, 3642281605
Language: English
Year: 2012
Edition: 1

Product desciption

Minimal Residual Disease And Circulating Tumor Cells In Breast Cancer 1st Edition Michail Ignatiadis by Michail Ignatiadis, Christos Sotiriou, Klaus Pantel (auth.), Michail Ignatiadis, Christos Sotiriou, Klaus Pantel (eds.) 9783642281594, 9783642281600, 3642281591, 3642281605 instant download after payment.

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.

Related Products